The video, which was shot by a person who was present in the ward, showed the doctor punching the patient, Arjun Singh, who was lying on the bed, in the face. The patient is seen resisting by kicking, while two other persons try to restrain both of them. Singh, a resident of Kupvi in Shimla, suffered a nose injury in the incident.
A teacher has been arrested for allegedly sexually harassing 24 girl students at a government school in Sirmaur district of Himachal Pradesh, officials said on Monday.
Heavy rains and landslides in Himachal Pradesh have resulted in multiple fatalities and widespread disruption, including road closures and train cancellations.
Four vehicles, carrying members of a marriage party, were trapped in the flash flood due to heavy rains at Haripur Khol village in Paonta Sahib, said Deputy Commissioner Sirmaur, PS Chauhan.
The Aam Aadmi Party (AAP), which contested the assembly polls in Himachal Pradesh for the first time, drew a blank securing just 1.10 per cent of the total votes cast.
Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.
The financial fraud, one of the biggest in the state as per records, was being investigated by the different departments of Himachal Pradesh for the past over four years.
Referring to Monday's rocket-propelled grenade attack at Punjab police intelligence headquarters in Mohali, he said, "it could have been Shimla also."
Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging.
Maruti Suzuki India (MSIL) plans to open new Arena Satellite showrooms as the country's largest carmaker aims to tap small towns and new markets, said a senior company executive, amid signs of recovery in rural demand and an approaching festival season. Senior executive officer for marketing and sales MSIL, Partho Banerjee, told Business Standard the company was aiming to penetrate deeper into markets and reach closer to its customers. "We have already had a concept of mobile showrooms in the Arena channel.
He said the incident occurred on August 12 at the busstahd and the police were informed about it Saturday evening.
US drug regulator's fiat on Mohali factory, after strictures on the two other major Indian units, has numerous negative implications.
The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.
Australian health regulator Therapeutic Goods Administration is investigating Indian pharma major Ranbaxy, following US allegations of the company falsifying data and test results of new drug applications, a media report says.
Ranbaxy has acceded to the request of Health Canada to quarantine drugs produced from its Paonta Sahib facility at Himachal Pradesh, North American country's newspapers reported, highlighting the trouble in store for the Japanese-controlled drug maker. Health Canada is a department of the government of Canada with responsibility for national public health.
The US Food and Drug Administration has issued two warning letters to Ranbaxy claiming procedural violations at its plants in Dewas and Paonta Sahib in India. Giuliani, a high-profile Republican leader and former US attorney in Manhattan, would provide advice and review compliance issues. Ranbaxy has been accused of selling generic drugs which did not meet FDA standards.
Delhi sweltered under intense heat as the Safdarjung observatory, considered the official marker of the national capital, noted a high of 43.8 degrees Celsius, four notches above the normal average.
The camera was switched on at 10:05 am through a series of commands issued from the spacecraft control centre of ISRO Telemetry, Tracking and Command Network here.
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.
'The customer is fast changing, and she demands newer experiences that wealth can buy.'
The company has received a Civil Investigative Demand from the US Department of Justice, Ranbaxy Laboratories said in a filing to the BSE.
All efforts should be on relief, restoration and rehabilitation, Nadda told reporters in Shimla after visiting the rain-affected areas of Poanta in Sirmaur and Shimla town.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Rediff readers suggest interesting names for Baba Ramdev's new denim brand.
The case was earlier heard by a different vacation bench which had on June 10 asked Sharma to substantiate his 'unfounded allegations' that the Indian pharma major was allegedly manufacturing and selling adulterated medicines.
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
No loss of life was reported in the incident.
The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.
The company did not comply to the 'good manufacturing practice' norms.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
BJP general secretary in-charge of Haryana Anil Jail also appealed to the Jats who have been protesting in Haryana to call off their agitation, which has badly hit life in the region, and return to their homes as their demands have been met.
The BJP launched an all-out and aggressive personalised campaign led by Prime Minister Narendra Modi himself, but voters went by local rather than national issues.
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.
Heavy rains continued to lash various parts of Himachal Pradesh, disrupting normal life in lower and mid hills while most of the rivers are in spate due to sudden rise in water level due to rains in catchments areas.
The Supreme Court on Monday posed some tough questions to a lawyer, asking him to substantiate his "unfounded allegations" in a PIL that Indian pharma major Ranbaxy Laboratories Ltd was allegedly manufacturing and selling adulterated medicines.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances